Vivimed receives Indian regulator nod to fabricate & marketplace Favipiravir Tablet & SunPharma

Vivimed receives Indian regulator nod to fabricate & marketplace Favipiravir Tablet & SunPharma

by admin- Monday, May 10th, 2021 04:25:01 PM

Vivimed Labs acquired Government of India approval to Manufacture and market Favipiravir Tablet 2 hundred mg & four hundr ed mg underneath Vivimed’s personal logo call “Favulous” across India.

It is used for the remedy of slight to mild cases of Covid-19 . Favipiravir is one of the main oral anti-viral remedy permitted in various nations for the capability remedy of patients with mild to mild Covid-19 disorder.

Sun Pharma symptoms voluntary licensing settlement with Eli Lilly
Sun Pharmaceutical Industries has entered right into a royalty-loose, non-distinctive voluntary licensing agreement with Eli Lilly and Company for expanding get admission to to Lilly’s drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India.

News Updates